Skip to content

Treatment of diverticulitis in patients with weakend immune systems

Conservative versus surgical treatment of diverticulitis in immunocompromised patients - Conservative versus surgical treatment of diverticulitis in immunocompromised patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57523
Enrollment
300
Registered
2025-04-30
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diverticulitis

Interventions

Disease course of diverticulitis&nbsp
&nbsp

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria:  Patients who were diagnosed with diverticulitis between 01-01-2017 and 01-03-2025 

Exclusion criteria

Exclusion criteria:  Age < 18Poor understanding of Dutch or English language 

Design outcomes

Primary

MeasureTime frame
Mortality 

Secondary

MeasureTime frame
Adverse eventsNumber of addmissionsTotal length of admissionLength of follow-upSurgical interventions

Countries

Netherlands

Contacts

Public ContactP.R.C. de Jong

Erasmus MC, Universitair Medisch Centrum Rotterdam

prcdejong@outlook.com0107040704

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)